VRPX
Virpax Pharmaceuticals, Inc. Common Stock
VRPX
VRPX
Delisted
VRPX was delisted on the 3rd of April, 2025.
16 hedge funds and large institutions have $2.17M invested in Virpax Pharmaceuticals, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 1 closing their positions.
Holders
16
Holders Change
–
Holders Change %
0%
% of All Funds
0.28%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
1
Increased
4
Reduced
4
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$441K |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$7K |
| 3 |
TRCT
3
Tower Research Capital (TRC)
New York
|
$5K |
| 4 |
4
Osaic Holdings
Scottsdale,
Arizona
|
$1K |
